Research workflow and filing intelligence for equity analysts
Equity Analyst AI is being built as an end-to-end workflow tool for equity analysts. The beta already covers watchlist monitoring, source-linked briefs, company context, and grounded follow-up. The broader vision is an agentic research workspace that can execute tasks end to end, from modelling and charts to report drafting, while staying grounded in evidence.
Currently in beta. I am working with a small group of analysts to refine the product. If you have been sent this link directly, I would genuinely value your feedback.
- The Company has effective disclosure controls and procedures as of December 27, 2025, ensuring compliance with SEC rules. E5
- On March 25, 2024, the European Commission opened a formal investigation into DMA compliance, followed by a EUR500 million fine on April 23, 2025. E1
- On March 21, 2024, the U.S. Department of Justice filed a civil antitrust lawsuit alleging monopolization in the smartphone market. E8
- The ongoing investigations and lawsuits could lead to significant financial penalties and operational changes for the Company. E1 E8
- The Company faces substantial legal risks related to antitrust allegations, which could impact market position and financial performance. E6 E8
| Ticker | AAPL |
| Form | 10-Q |
| Filed | 2026-01-30 |
| Impact | High (75/100) |
| Accession No. | 0000320193-26-000006 |
- The Company has effective disclosure controls and procedures as of December 27, 2025, ensuring compliance with SEC rules. E5
- On March 25, 2024, the European Commission opened a formal investigation into DMA compliance, followed by a EUR500 million fine on April 23, 2025. E1
- On March 21, 2024, the U.S. Department of Justice filed a civil antitrust lawsuit alleging monopolization in the smartphone market. E8
- The ongoing investigations and lawsuits could lead to significant financial penalties and operational changes for the Company. E1 E8
- The Company faces substantial legal risks related to antitrust allegations, which could impact market position and financial performance. E6 E8
Hi Team,
I wanted to update you on the latest significant developments regarding the Company. On March 25, 2024, the European Commission initiated a formal investigation into the Company's compliance with the EU Digital Markets Act, which resulted in a EUR500 million fine on April 23, 2025. Additionally, on March 21, 2024, the U.S. Department of Justice filed a civil antitrust lawsuit alleging monopolization in the smartphone market.
These legal challenges could lead to substantial financial penalties and operational changes. The Company is actively managing these risks and has maintained effective disclosure controls as of late 2025.
Please let me know if you need a more detailed briefing or additional information.
Best regards,
[Your Name]
From filing to brief in minutes
Add tickers to your watchlist. When a company files with the SEC, you get an AI summary with source citations. No manual checking, no delay.
- Amazon issued multiple note tranches maturing from 2028 through 2056.
- The total principal amount was approximately $36.9B across the offering.
- The financing strengthens liquidity and supports future capex and strategic flexibility.
- Revenue rose sharply year over year, led by continued demand across data-centre workloads. E2
- Free cash flow and profitability both improved, supporting the current investment cycle. E5
- The filing keeps the core debate centered on sustainability of AI demand and margin durability rather than a near-term slowdown. E6
- Watch for customer concentration, supply tightness, and whether capex intensity normalizes over the next few quarters. E9
The note issuance improves liquidity flexibility and gives Amazon more room to fund capex and strategic priorities across the next few years.
The key question is not access to capital, but how effectively management deploys that larger balance-sheet capacity into growth and returns.
Watch next quarter for commentary on investment cadence and for any change in funding mix or maturity strategy.
What is being built now
The roadmap is being shaped by feedback from current beta users. These are the areas in active development. If any of these would be particularly useful to your workflow, I want to hear about it.
- Company one-pagers and full research reports (PDF, Note)
- DCF workbooks and forecast skeletons (XLSX)
- Peer comps and KPI trend charts
- Targeted extraction from filings and exhibits
- Earnings recap and guidance summaries
- Earnings call transcripts
- Earnings press releases and presentations
- Company investor relations pages
- UK equity coverage (initial list)
- KPI trend charts inline with ask answers
- Comparative tables across companies or periods
- Exportable data outputs from research queries
Current product surfaces
These are the real surfaces already in the product today: the dashboard, the briefs, and the company pages that keep follow-up work in context.
Dashboard
Inbox, overview, and macro context sit side by side in the product. The dashboard is built for quick triage rather than generic browsing.
Filing briefs
Structured brief pages combine a readable summary with evidence-linked follow-up so the output remains inspectable instead of hand-wavy.
Company pages
Overview, financials, and risks all live in the same company context, so the next question or task starts from the right evidence base.
Follow-up questions are grounded in the actual filing
Generic AI tools produce confident answers with no traceable source. In equity research, that is a problem. Every Ask AI answer in this product includes evidence tags that link back to the specific paragraph in the original filing that was used to generate the response.
Deep mode expands context across a company's full filing history and KPI data. Standard mode is faster and grounded in the current brief.
| Capability | Equity Analyst AI | Generic AI chat |
|---|---|---|
| Filing monitoring and alerts | Yes, continuous | No |
| Source-linked evidence | Yes, paragraph-level | No |
| Impact scoring and triage | Yes | No |
| KPI trend context | Yes, from SEC XBRL | Not reliably |
| Workflow around your coverage | Yes | You provide the context |
This is a beta product being shaped with feedback from analysts
The core monitoring and brief workflow is working. What I am trying to understand now is where it fits into real analyst workflows, what is missing, and what is worth building next.
If you have been sent this link, I would find your perspective genuinely useful. You do not need to be polished about it. Rough feedback on what is confusing, missing, or not quite right is more valuable than polished praise.
- 01Does the monitoring and brief workflow fit how you actually triage filings today?
- 02Which sources are missing that would make this genuinely useful to your day-to-day?
- 03What would Research Studio need to produce to be worth using over your current process?
- 04Is there anything in the product that feels off, confusing, or simply wrong?
Beta access is by request. I review each request personally. If you are an equity analyst, portfolio manager, or work in a related research role, I want to hear from you.
No automated marketing. I will follow up personally. Informational only. Not investment advice.